LA Private

September 2024

Stocks of the Hour: Imugene, RocketDNA, Marquee Resources

Imugene (ASX:IMU) announced promising results from its Phase 1b clinical trial with azer-cel, in patients with relapsed/refractory diffuse large B cell lymphoma. All enrolled patients had cancer that had returned following autologous CAR T therapy, a high unmet need for this patient population. Shares are trading 25.81 per cent higher at 7.8 cents. RocketDNA (ASX:RKT) […]

Stocks of the Hour: Imugene, RocketDNA, Marquee Resources Read More »

China’s manufacturing slump continues

The latest official survey of activity in China’s manufacturing sector confirms that August was another sluggish month for the country’s economy. The official survey from the National Bureau of Statistics showed that manufacturing activity shrank for the fourth consecutive month. The official purchasing managers’ index (PMI) fell to 49.1 in August from 49.4 in July,

China’s manufacturing slump continues Read More »

Is the oil market stuck in a rut?

Oil prices experienced another weak week, culminating in a 3% decline on Friday. West Texas Intermediate (WTI) crude closed at $73.55 per barrel, marking the third consecutive weekly loss. Brent crude also fell, ending the week at $76.93. For August, both benchmarks declined by 0.66%. The U.S. rig count remained unchanged at 483, according to

Is the oil market stuck in a rut? Read More »